Motley Fool Australia

Cochlear Limited (ASX: COH) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Cochlear Limited (ASX: COH) Latest News

increase in asx medical software share price represented by doctor making excited hands up gesture

2 ASX healthcare shares to buy today

More »

Ideas and innovation

4 outstanding ASX 200 shares to buy with $4,000

More »

asx brokers

Top brokers name 3 ASX shares to buy today

More »

blocks trending up

3 sublime ASX growth shares to buy this month

More »

US flag and senate building with blue sky in background

The 10 ASX stocks worst hit by a Biden US presidential election win

More »

Broker updates are mixed on these 6 high profile ASX 200 shares

More »

Millionaire and Wealthy man with money raining down, cheap stocks

Here’s where I would spend $10,000 on ASX shares today

More »

ASX 200

The ASX 200 slid 0.72% lower today

More »

About Cochlear Limited (ASX: COH)

Cochlear Limited (COH) is a global leader in implantable hearing devices. The company manufactures and distributes cochlear implantable devices for hearing impaired.

Based in Sydney, Cochlear has operations in more than 20 countries, distributing its products in America, Asia Pacific, Europe, the Middle East and Africa. It offers three main products: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.

Cochlear was formed in 1981, with COH shares first listing on the ASX almost 15 years later in 1995. Since then, the Cochlear share price has risen exponentially and the company is now one of the largest-listed companies on the ASX.

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
21 Oct 2020 Dig Howitt Issued 4 $1,062,703
21 Oct 2020 Dig Howitt Issued 21 $4,715,053
03 Sep 2020 Bruce Robinson Buy 75 $14,601
26 Aug 2020 Bruce Robinson Buy 75 $15,072
25 Aug 2020 Shah Abbas Hussain Transfer 226 $45,595
25 Aug 2020 Shah Abbas Hussain Transfer 226 $45,595
25 Aug 2020 Shah Abbas Hussain Buy 1 $203,080
25 Aug 2020 Dig Howitt Sell 21 $4,481,550
21 Aug 2020 Dig Howitt Exercise 21 $3,362,901
21 Aug 2020 Dig Howitt Buy 21 $3,362,901
19 Aug 2020 Dig Howitt Cancelled 1 $380,222
19 Aug 2020 Dig Howitt Cancelled 25 $5,280,212
19 Aug 2020 Dig Howitt Exercise 21 $4,570,660
19 Aug 2020 Dig Howitt Buy 3 $684,736
19 Aug 2020 Dig Howitt Exercise 3 $684,736
24 Jun 2020 Bruce Robinson Transfer 933 $180,236
30 Apr 2020 Dig Howitt Buy 214 $29,960
30 Apr 2020 Michael Daniell Buy 214 $29,960
30 Apr 2020 Roderic (Rick) Holliday-Smith Buy 214 $29,960
30 Apr 2020 Catriona Deans Buy 214 $29,960
30 Apr 2020 Andrew Denver Buy 214 $29,960
30 Apr 2020 Yasmin Allen Buy 214 $29,960
30 Apr 2020 Donal O'Dwyer Buy 214 $29,960
30 Apr 2020 Glen Boreham Buy 214 $29,960
30 Apr 2020 Bruce Robinson Buy 214 $29,960
30 Apr 2020 Shah Abbas Hussain Buy 66 $9,240
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Ms Christine Frances McLoughlin Non-Executive Director Nov 2020
Mr Michael Grenfell Daniell Non-Executive Director Jan 2020
Mr Roderic (Rick) Holliday-Smith Non-Executive Director,Non-Executive Chairman Mar 2005
Ms Catriona Alison Deans Non-Executive Director Jan 2015
Mr Andrew Leslie Denver Non-Executive Director Feb 2007
Ms Yasmin Anita Allen Non-Executive Director Aug 2010
Mr Glen Francis Boreham Non-Executive Director Jan 2015
Professor Bruce Gregory Robinson Non-Executive Director Dec 2016
Mr Dig Howitt President,Chief Executive Officer,Managing Director Jul 2017
Mr Shah Abbas Hussain Non-Executive Director Nov 2018
Mr Ray Jarman Company Secretary Feb 2017
Ray Jarman Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 28,405,386 43.24%
J P Morgan Nominees Australia Pty Limited 11,371,030 17.31%
Citicorp Nominees Pty Limited 4,113,509 6.26%
National Nominees Limited 1,682,907 2.56%
BNP Paribas Noms Pty Ltd <DRP> 1,540,107 2.34%
BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C> 1,132,094 1.72%
HSBC Custody Nominees (Australia) Limited GSCO ECA 738,643 1.12%
Australian Foundation Investment Company Limited 323,715 0.49%
HSBC Custody Nominees (Australia) Limited (NT Comnwlth Super CORP) 300,693 0.46%
Netwealth Investments Limited <Wrap Services A/C> 231,860 0.35%
Citicorp Nominees Pty Limited <Colonial First State INV A/C> 226,944 0.35%
Mr Christopher Graham Roberts 162,173 0.25%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> 103,774 0.16%
PGA (Investments) Pty Ltd 100,118 0.15%
National Nominees Limited <DB A/C> 86,230 0.13%
AMP Life Limited 79,421 0.12%
HSBC Custody Nominees (Australia) Limited A/C 2 71,519 0.11%
UBS Nominees Pty Ltd 70,592 0.11%
Avanteos Investments Limited <Encircle IMA A/C> 68,964 0.10%
Custodial Services Limited <Beneficiaries Holding A/C> 67,214 0.10%
Show more

FAQ

Will Cochlear pay a dividend in 2020?

Cochlear typically pays twice yearly dividends in April and October. Over the past five years, the company’s dividends have all been fully franked. Prior to this, Cochlear’s dividends varied between fully franked and partially franked with only one dividend over this time being 100% unfranked. Cochlear’s last interim dividend of $1.60 per share was paid on 17 April 2020. The medical devices company has an impressive dividend payment history dating back to 1997. In March 2020, however, Cochlear withdrew its FY20 earnings guidance and announced a capital raising to enhance its liquidity. This was following the negative impacts of COVID-19 on its revenue streams. It also announced suspension of the company’s dividend until trading conditions improve. 

Does Cochlear offer a DRP?

At at 17 June 2020, Cochlear does not offer a dividend reinvestment plan.